<code id='70827B8D92'></code><style id='70827B8D92'></style>
    • <acronym id='70827B8D92'></acronym>
      <center id='70827B8D92'><center id='70827B8D92'><tfoot id='70827B8D92'></tfoot></center><abbr id='70827B8D92'><dir id='70827B8D92'><tfoot id='70827B8D92'></tfoot><noframes id='70827B8D92'>

    • <optgroup id='70827B8D92'><strike id='70827B8D92'><sup id='70827B8D92'></sup></strike><code id='70827B8D92'></code></optgroup>
        1. <b id='70827B8D92'><label id='70827B8D92'><select id='70827B8D92'><dt id='70827B8D92'><span id='70827B8D92'></span></dt></select></label></b><u id='70827B8D92'></u>
          <i id='70827B8D92'><strike id='70827B8D92'><tt id='70827B8D92'><pre id='70827B8D92'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:2479
          Adobe

          The chief executive of the country’s biggest hospital chain said Thursday that labor costs are now lower as a percent of revenue than they were before the pandemic.

          “And again, that’s in the face of a very difficult labor market,” HCA Healthcare CEO Sam Hazen noted on the company’s second quarter earnings call. Health care providers and insurers are in the full swing of releasing their second-quarter earnings, and HCA tends to outperform its peers.

          advertisement

          Hospitals struggled with the high cost of nurses throughout the Covid-19 pandemic, but HCA on Thursday said several of its workforce initiatives are paying off.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Medicare Advantage plans can’t deny care with AI, CMS warns
          Medicare Advantage plans can’t deny care with AI, CMS warns

          AdobeInrecentmonths,thefederalgovernmenthasrepeatedlytoldMedicareAdvantageinsurersthattheycannotusea

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

          CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact